The Neurodiagnostic And Monitoring Devices Market in US is being driven by Increasing incidences and prevalence of neurological conditions
The Neurodiagnostic And Monitoring Devices Market in US is expected to grow at a CAGR of 5.9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 822.9 million. In the dynamic landscape of healthcare, medical equipment procurement and maintenance represent a substantial portion of operational expenditures for organizations. The advent of advanced technologies, such as wearable neurodiagnostic and monitoring devices, has revolutionized patient care by enhancing affordability and convenience. These innovations enable simpler monitoring processes, leading to increased patient adherence and better health outcomes. Neurodiagnostic and monitoring procedures are essential in hospitals, clinics, and Ambulatory Surgery Centers (ASCs), facilitating the diagnosis and investigation of neurological disorders for subsequent interventions. The US neurodiagnostic and monitoring devices market is poised for growth, driven by these technological advancements and evolving healthcare needs.
Get more information on Neurodiagnostic And Monitoring Devices Market in US by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
202 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.9% |
Market growth 2025-2029 |
USD 822.9 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
5.4 |
Key countries |
US |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Neurodiagnostic and Monitoring Devices Market in the US encompasses various technologies including Electroencephalography (EEG), Electromyography (EMG), and Electrocardiography (ECG). These techniques are advanced by Neuroimaging methods like Quantitative EEG (qEEG), Event-Related Potentials (ERP), Magnetoencephalography (MEG), and signal processing tools such as Artificial Neural Networks (ANNs), Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), and data analysis methods like Spectral Analysis, Time-Frequency Analysis, and Wavelet Analysis. Feature extraction, Cloud Computing, and Big Data Analytics are integral to enhancing diagnostic accuracy. Patient engagement, education, home healthcare, personalized medicine, and precision medicine are key areas of application. Neuroscience fields like cognitive neuroscience, brain plasticity, neurorehabilitation therapy, cognitive training, and digital health are also impacted. Data privacy and security are crucial considerations, with emerging technologies like AI, ML, DL, and computer vision playing a significant role.
The Neurodiagnostic and Monitoring Devices Market in the US is a significant segment of the global Healthcare Equipment Market, encompassing innovative solutions for Evoked Potentials, Neuromuscular Disorders, Seizure Monitoring, Sleep Disorders, and Brain Mapping, among others. Technavio, a leading global technology research and consulting firm, positions this market within the broader Healthcare Equipment industry, which covers R&D of capital equipment, instruments, implants, accessories, and consumables for disease diagnosis, monitoring, and treatment. The Healthcare Equipment Market size is determined by the combined revenue of diagnostic equipment and device manufacturers across various therapy areas. This industry is categorized into Devices, which include advanced, differentiated, and clinically tested data-driven devices.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted